glucuronic acid has been researched along with deferoxamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gavini, E; Giunchedi, P; Porcu, EP; Rassu, G; Roldo, M; Salis, A | 1 |
| Chen, X; Gu, Z; Li, H; Ma, L; Qi, X; Tan, H; Tian, M; You, C | 1 |
2 other study(ies) available for glucuronic acid and deferoxamine
| Article | Year |
|---|---|
Composite chitosan/alginate hydrogel for controlled release of deferoxamine: A system to potentially treat iron dysregulation diseases.
Topics: Alginates; Chemistry, Pharmaceutical; Chitosan; Deferoxamine; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Glucuronic Acid; Hexuronic Acids; Hydrogels; Iron; Lactic Acid; Metabolic Diseases; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Viscosity | 2016 |
Synthesis and evaluation of oxidation-responsive alginate-deferoxamine conjugates with increased stability and low toxicity.
Topics: Alginates; Cell Survival; Chemistry Techniques, Synthetic; Deferoxamine; Drug Stability; Glucuronic Acid; Hexuronic Acids; Human Umbilical Vein Endothelial Cells; Humans; Iron; Models, Molecular; Molecular Conformation; Molecular Weight; Oxidation-Reduction; Water | 2016 |